731 related articles for article (PubMed ID: 18806487)
1. Vitiligo-like primary melanoma.
Lugo-Somolinos A; Sánchez JL; Garcia ME
Am J Dermatopathol; 2008 Oct; 30(5):451-4. PubMed ID: 18806487
[TBL] [Abstract][Full Text] [Related]
2. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo.
Onsun N; Büyükbabani N; Ummetoğlu O; Cebeci F
J Dermatol; 2009 Nov; 36(11):612-5. PubMed ID: 19878396
[TBL] [Abstract][Full Text] [Related]
3. Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis).
El-Darouti MA; Marzouk SA; Azzam O; Fawzi MM; Abdel-Halim MR; Zayed AA; Leheta TM
Eur J Dermatol; 2006; 16(1):17-22. PubMed ID: 16436337
[TBL] [Abstract][Full Text] [Related]
4. Dermatoscopy of blue vitiligo.
Chandrashekar L
Clin Exp Dermatol; 2009 Jul; 34(5):e125-6. PubMed ID: 19438538
[TBL] [Abstract][Full Text] [Related]
5. [Malignant melanoma, leukoderma and vitiligo].
Kraus L; Landthaler M
Z Hautkr; 1980 Feb; 55(4):218-31. PubMed ID: 6996365
[TBL] [Abstract][Full Text] [Related]
6. [Vulvar melanosis and vitiligo].
Haraszti G; Kemény L; Bónis B; Dobozi A
Orv Hetil; 1998 Apr; 139(14):825-8. PubMed ID: 9569730
[TBL] [Abstract][Full Text] [Related]
7. Amelanotic lentigo maligna melanoma manifesting as a dermatitislike plaque.
Borkovic SP; Schwartz RA
Arch Dermatol; 1983 May; 119(5):423-5. PubMed ID: 6847222
[TBL] [Abstract][Full Text] [Related]
8. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.
Le Gal FA; Avril MF; Bosq J; Lefebvre P; Deschemin JC; Andrieu M; Dore MX; Guillet JG
J Invest Dermatol; 2001 Dec; 117(6):1464-70. PubMed ID: 11886510
[TBL] [Abstract][Full Text] [Related]
9. [Spontaneous regression and leukoderma in malignant melanoma].
Happle R; Schotola I; Macher E
Hautarzt; 1975 Mar; 26(3):120-3. PubMed ID: 1126845
[TBL] [Abstract][Full Text] [Related]
10. Vitiligo and malignant melanoma.
Fodor J; Bodrogi I
Neoplasma; 1975; 22(4):445-8. PubMed ID: 1196428
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune vitiligo: detection of antibodies to melanin-producing cells.
Hertz KC; Gazze LA; Kirkpatrick CH; Katz SI
N Engl J Med; 1977 Sep; 297(12):634-7. PubMed ID: 331108
[TBL] [Abstract][Full Text] [Related]
12. Childhood subungual melanoma in situ in diffuse nail melanosis beginning as expanding longitudinal melanonychia.
Antonovich DD; Grin C; Grant-Kels JM
Pediatr Dermatol; 2005; 22(3):210-2. PubMed ID: 15916566
[TBL] [Abstract][Full Text] [Related]
13. Melanocytic aggregation in the skin: diagnostic clues from lentigines to melanoma.
de Giorgi V; Sestini S; Massi D; Lotti T
Dermatol Clin; 2007 Jul; 25(3):303-20, vii-viii. PubMed ID: 17662896
[TBL] [Abstract][Full Text] [Related]
14. Hypopigmentation, vitiligo, and melanoma. New data, more enigmas.
Nordlund JJ
Arch Dermatol; 1987 Aug; 123(8):1005-8. PubMed ID: 3631979
[No Abstract] [Full Text] [Related]
15. Metastatic melanoma and vitiligo: a case report.
Buljan M; Situm M; Lugović L; Vucić M
Acta Dermatovenerol Croat; 2006; 14(2):100-3. PubMed ID: 16859616
[TBL] [Abstract][Full Text] [Related]
16. [Differential diagnosis of primary melanoma of the skin].
Blinov NN; Anisimov VV; Leonchuk AD
Sov Med; 1990; (1):99-102. PubMed ID: 2349530
[No Abstract] [Full Text] [Related]
17. Longitudinal melanonychia and melanoma: an unusual case presentation.
Daniel CR
Dermatol Surg; 2001 Mar; 27(3):294-5. PubMed ID: 11277899
[No Abstract] [Full Text] [Related]
18. Immune mechanisms in vitiligo.
Bystryn JC
Immunol Ser; 1989; 46():447-73. PubMed ID: 2488866
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity as an aetiological factor in vitiligo.
Rezaei N; Gavalas NG; Weetman AP; Kemp EH
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
[TBL] [Abstract][Full Text] [Related]
20. [Malignant melanoma--pathological-anatomical aspects].
Jonsson N
Lakartidningen; 1976 Feb; 73(7):519-23. PubMed ID: 1250042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
